combretastatin has been researched along with Lung Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, X; Liu, Z; Wang, H; Zhang, B; Zhang, H; Zhong, W | 1 |
| Antoccia, A; Leone, S; Méndez-Callejas, GM; Tanzarella, C | 1 |
| Edelman, MJ | 1 |
| Akita, H; Hori, K; Kawaguchi, T; Saito, S; Sato, H; Sato, Y; Sugiyama, K | 1 |
1 review(s) available for combretastatin and Lung Neoplasms
| Article | Year |
|---|---|
Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Bibenzyls; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Resistance, Neoplasm; Epothilones; Humans; Lung Neoplasms; Paclitaxel; Polyglutamic Acid; Tubulin Modulators; Vinblastine; Vinorelbine | 2009 |
3 other study(ies) available for combretastatin and Lung Neoplasms
| Article | Year |
|---|---|
Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Matrix Metalloproteinases; Tubulin; Tubulin Modulators | 2022 |
Combretastatin A-4 induces p53 mitochondrial-relocalisation independent-apoptosis in non-small lung cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bibenzyls; Carcinoma, Non-Small-Cell Lung; Cytochromes c; Humans; Lung Neoplasms; Mitochondria; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2014 |
Differential relationship between changes in tumour size and microcirculatory functions induced by therapy with an antivascular drug and with cytotoxic drugs. implications for the evaluation of therapeutic efficacy of AC7700 (AVE8062).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Blood Flow Velocity; Cell Division; Doxorubicin; Lung Neoplasms; Male; Microcirculation; Mitomycin; Neoplasm Transplantation; Rats; Stilbenes; Treatment Outcome | 2003 |